HCV: ESPGHAN issues recommendations for pediatric treatment

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • The European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) has issued a position paper regarding the treatment of pediatric HCV.

Why this matters

  • Ledipasvir/sofosbuvir (LDV/SOF) and sofosbuvir/ribavirin (SOF/RBV) are approved in the US/Europe fo...